Development of a high-throughput Candida albicans biofilm chip

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Srinivasan, Anand ^a   Uppuluri, Priya ^b   Lopez Ribot, Jose ^b   Ramasubramanian, Anand K ^a,b  

^a The University of Texas at San Antonio   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; AUTOMATION; BIOFILM; BIOTECHNOLOGY; CANDIDA ALBICANS; CELL GROWTH; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CULTURE TECHNIQUE; ELECTRONICS; FUNGUS CULTURE; HIGH THROUGHPUT SCREENING; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; NONHUMAN; PROCESS DEVELOPMENT; ROBOTICS; SCANNING ELECTRON MICROSCOPY; STRUCTURE ANALYSIS; VALIDITY; YEAST CELL; CONFOCAL MICROSCOPY; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; ULTRASTRUCTURE;

CANDIDA ALBICANS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; FLUCONAZOLE; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING;

EID: 79955526276     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019036     Document Type: Article

References (39)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, et al. (1999) Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 29: 239-244.
2. Pfaller MA, Diekema DJ, (2007) Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20: 133-163.
3. Gudlaugsson O, Gillespie S, Lee K, Vande Berg J, Hu J, et al. (2003) Attributable mortality of nosocomial candidemia, revisited. Clin Infect Dis 37: 1172-1177.
4. Viudes A, Peman J, Canton E, Ubeda P, Lopez-Ribot JL, et al. (2002) Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur J Clin Microbiol Infect Dis 21: 767-774.
5. Zaoutis TE, Argon J, Chu J, Berlin JA, Walsh TJ, et al. (2005) The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis. Clin Infect Dis 41: 1232-1239.
6. Kojic EM, Darouiche RO, (2004) Candida infections of medical devices. Clin Microbiol Rev 17: 255-267.
7. Ramage G, Martinez JP, Lopez-Ribot JL, (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6: 979-986.
8. Darouiche RO, (2004) Treatment of infections associated with surgical implants. N Engl J Med 350: 1422-1429.
9. Crump JA, Collignon PJ, (2000) Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 19: 1-8.
10. Bryers JD, (2008) Medical biofilms. Biotechnol Bioeng 100: 1-18.
11. Costerton JW, Cheng KJ, Geesey GG, Ladd TI, Nickel JC, et al. (1987) Bacterial biofilms in nature and disease. Annu Rev Microbiol 41: 435-464.
12. Donlan RM, (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8: 881-890.
13. Blankenship JR, Mitchell AP, (2006) How to build a biofilm: a fungal perspective. Curr Opin Microbiol 9: 588-594.
14. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL, (2005) Candida biofilms: an update. Eukaryot Cell 4: 633-638.
15. Jabra-Rizk MA, Falkler WA, Meiller TF, (2004) Fungal biofilms and drug resistance. Emerg Infect Dis 10: 14-19.
16. Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, et al. (2007) Putative role of beta-1,3 glucans in Candida albicans biofilm resistance. Antimicrob Agents Chemother 51: 510-520.
17. Nett JE, Crawford K, Marchillo K, Andes DR, (2010) Role of Fks1p and matrix glucan in Candida albicans biofilm resistance to an echinocandin, pyrimidine, and polyene. Antimicrob Agents Chemother 54: 3505-3508.
18. Nett JE, Sanchez H, Cain MT, Andes DR, (2010) Genetic basis of Candida biofilm resistance due to drug-sequestering matrix glucan. J Infect Dis 202: 171-175.
19. Perumal P, Mekala S, Chaffin WL, (2007) Role for cell density in antifungal drug resistance in Candida albicans biofilms. Antimicrob Agents Chemother 51: 2454-2463.
20. Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL, (2002) Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973-980.
21. Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J, (2009) Our current understanding of fungal biofilms. Crit Rev Microbiol 35: 340-355.
22. Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, et al. (2008) A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing. Nat Protoc 3: 1494-1500.
23. Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL, (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475-2479.
24. Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, et al. (2010) Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 6: e1000828.
25. Fesenko DO, Nasedkina TV, Prokopenko DV, Mirzabekov AD, (2005) Biosensing and monitoring of cell populations using the hydrogel bacterial microchip. Biosens Bioelectron 20: 1860-1865.
26. Gefen O, Balaban NQ, (2008) The Moore's Law of microbiology- towards bacterial culture miniaturization with the micro-Petri chip. Trends Biotechnol 26: 345-347.
27. Groisman A, Lobo C, Cho H, Campbell JK, Dufour YS, et al. (2005) A microfluidic chemostat for experiments with bacterial and yeast cells. Nat Methods 2: 685-689.
28. Hart T, Zhao A, Garg A, Bolusani S, Marcotte EM, (2009) Human cell chips: adapting DNA microarray spotting technology to cell-based imaging assays. PLoS One 4: e7088.
29. Ingham CJ, Sprenkels A, Bomer J, Molenaar D, van den Berg A, et al. (2007) The micro-Petri dish, a million-well growth chip for the culture and high-throughput screening of microorganisms. Proc Natl Acad Sci U S A 104: 18217-18222.
30. Narayanaswamy R, Niu W, Scouras AD, Hart GT, Davies J, et al. (2006) Systematic profiling of cellular phenotypes with spotted cell microarrays reveals mating-pheromone response genes. Genome Biol 7: R6.
31. Lee MY, Kumar RA, Sukumaran SM, Hogg MG, Clark DS, et al. (2008) Three-dimensional cellular microarray for high-throughput toxicology assays. Proc Natl Acad Sci U S A 105: 59-63.
32. Garnier G, Duskova-Smrckova M, Vyhnalkova R, van de Ven TGM, Revol JF, (2000) Association in solution and adsorption at an air-water interface of alternating copolymers of maleic anhydride and styrene. Langmuir 16: 3757-3763.
33. Ivanova EP, Pham DK, Demyashev GM, Nicolau DV, (2002) Oligonucleotide/poly(l-lysine) complexes attachment on poly(styrene/maleic acid) and poly(styrene/maleic anhydride polymeric surfaces. Proceedings of SPIE 4937.
34. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T, et al. (2001) Biofilm formation by the fungal pathogen Candida albicans: Development, architecture, and drug resistance. Journal of Bacteriology 183: 5385-5394.
35. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL, (2001) Characteristics of biofilm formation by Candida albicans. Rev Iberoam Micol 18: 163-170.
36. Nobile CJ, Mitchell AP, (2006) Genetics and genomics of Candida albicans biofilm formation. Cell Microbiol 8: 1382-1391.
37. Uppuluri P, Pierce CG, Lopez-Ribot JL, (2009) Candida albicans biofilm formation and its clinical consequences. Future Microbiology 4: 1235-1237.
38. Wilson LS, Reyes CM, Stolpman M, Speckman J, Allen K, et al. (2002) The direct cost and incidence of systemic fungal infections. Value Health 5: 26-34.
39. Odabasi Z, Paetznick V, Rex JH, O-Z L, (2007) Effects of serum on in vitro susceptibility testing of echinocandins. Antimicrob Agents Chemother 51: 4214-4216.